The Effect of Dexmedetomidine on Agitation During Weaning From Mechanical Ventilation
Recruiting now · Not applicable
Conditions studied: Dexmedetomidine
In brief
This study aims to evaluate the effect of dexmedetomidine on the level of agitation during the weaning process from mechanical ventilation in critically ill patients.
Key facts
- Study ID
- NCT07066605
- Run by
- Sohag University
- People needed
- 62
- Starts
- 2025-06-13
- Expected to finish
- 2025-12-30
- Last updated by the study team
- 2025-07-15
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult ICU patients (≥18 years).
- On mechanical ventilation ≥24 hours.
- Clinically ready for weaning.
- Agitation score RASS ≥ +1 during spontaneous breathing trial.
- Intubation for at least 4 days: 2 weeks.
You may not qualify if…
- Known hypersensitivity to dexmedetomidine.
- Hemodynamic instability (HR < 50 bpm or MAP < 60 mmHg).
- Neurological impairment affecting level of consciousness.
- Pregnancy or lactation.
Where it is running
- Sohag University Hospital — Sohag, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.